A functional association between merlin and HEI10, a cell cycle regulator

Oncogene

Volumn 25, Issue 32, 2006, Pages 4389-4398

  Gronholm M ^a,f   Muranen, T ^a   Toby, G G ^b   Utermark, T ^c   Hanemann, C O ^d   Golemis, E A ^b   Carpen O ^a,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d PENINSULA MEDICAL SCHOOL   (United Kingdom)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f Neuroscience Program   (Finland)

Author keywords

ERM; HEI10; NF2

Indexed keywords

CYCLIN B; CYCLIN B BINDING PROTEIN; EZRIN; MERLIN; MIMOSINE; NOCODAZOLE; PROTEIN HEI10; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; GENE CONSTRUCT; GENE INACTIVATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; NEURILEMOMA; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; SCHWANN CELL; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; HUMANS; NEUROFIBROMIN 2; RATS;

EID: 33746541581     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209475     Document Type: Article

References (38)

1. Alfthan K, Heiska L, Grönholm M, Renkema GH, Carpén O. (2004). J Biol Chem 279: 18559-18566.
2. Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y. (1994). Hum Mol Gen 3: 565-568.
3. Bretscher A, Edwards K, Fehon RG. (2002). Nat Rev Mol Cell Biol 3: 586-599.
4. Burkhard P, Stetefeld J, , Strelkov SV. (2001). Trends Cell Biol 11: 82-88.
5. Chambers DN, Bretscher A. (2005). Biochemistry 44: 3926-3932.
6. den Bakker MA, Tascilar M, Riegman PH, Hekman AC, Boersma W, Janssen PJ et al. (1995). Am J Pathol 147: 1339-1349.
7. Fabbro M, Henderson BR. (2003). Exp Cell Res 282: 59-69.
8. Geiger KD, Stoldt P, Schlote W, Derouiche A. (2000). Am J Pathol 157: 1785-1793.
9. Gonzalez-Agosti C, Wiederhold T, Herndon ME, Gusella J, Ramesh V. (1999). J Biol Chem 274: 34438-34442.
10. Gonzalez-Agosti C, Xu L, Pinney D, Beauchamp R, Hobbs W, Gusella J et al. (1996). Oncogene 13: 1239-1247.
11. Grönholm M, Sainio M, Zhao F, Heiska L, Vaheri A, Carpén O. (1999). J Cell Sci 112: 895-904.
12. Grönholm M, Vossebein L, Carlson CR, Kuja-Panula J, Teesalu T, Alfthan K et al. (2003). J Biol Chem 278: 41167-41172.
13. Gutmann DH, Sherman L, Seftor L, Haipek C, Hoang Lu K, Hendrix M. (1999). Hum Mol Genet 8: 267-275.
14. Gyuris J, Golemis E, Chertkov H, Brent R. (1993). Cell 75: 791-803.
15. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Muller HW. (1998). Glia 23: 89-98.
16. Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M et al. (2004). Cancer J 10: 20-26.
17. Huynh DP, Pulst SM. (1996). Oncogene 13: 73-84.
18. Ilmonen S, Vaheri A, Asko-Seljavaara S, Carpén O. (2005). Mod Pathol 18: 872.
19. Khanna C, Wan XL, Bose S, Cassaday R, Olomu O, Mendoza A et al. (2004). Nat Med 10: 182-186.
20. Kissil JL, Johnson KC, Eckman MS, Jacks T. (2002). J Biol Chem 277: 10394-10399.
21. Louis DN, Ramesh V, Gusella JF. (1995). Brain Pathol 5: 163-172.
22. Lutchman M, Rouleau GA. (1995). Cancer Res 55: 2270-2274.
23. Mäkitie T, Carpén O, Vaheri A, Kivelä T. (2001). Invest Ophthalmol Vis Sci 42: 2442-2449.
24. McClatchey AI. (2003). Nat Rev Cancer 3: 877-883.
25. Mine N, Kurose K, Konishi H, Araki T, Nagai H, Emi M. (2001). Jpn J Cancer Res 92: 135-139.
26. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA et al. (2001). Gene Dev 15: 968-980.
27. Muranen T, Grönholm M, Renkema GH, Carpén O. (2005). Oncogene 24: 1150-1158.
28. Pineau P, Marchio A, Cordina E, Tiollais P, Dejean A. (2003). Int J Cancer 106: 216-223.
29. Rosenbaum C, Kluwe L, Mautner VF, Friedrich RE, Muller HW, Hanemann CO. (1998). Neurobiol Dis 5: 55-64.
30. Sainio M, Zhao F, Heiska L, Turunen O, den Bakker M, Zwarthoff E et al. (1997). J Cell Sci 110: 2249-2260.
31. Schulze KM, Hanemann CO, Muller HW, Hanenberg H. (2002). Hum Mol Genet 11: 69-76.
32. Shaw RJ, McClatchey AI, Jacks T. (1998). J Biol Chem 273: 7757-7764.
33. Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H et al. (1997). Oncogene 15: 2505-2509.
34. Smith AP, Weeraratna AT, Spears JR, Meltzer PS, Becker D. (2004). Cancer Biol Ther 3: 104-109.
35. Toby GG, Gherraby W, Coleman TR, Golemis EA. (2003). Mol Cell Biol 23: 2109-2122.
36. Tynninen O, Carpén O, Jääskeläinen J, Paavonen T, Paetau A. (2004). Neuropathol Appl Neurobiol 30: 472-477.
37. Xiao GH, Beeser A, Chernoff J, Testa JR. (2002). J Biol Chem 277: 883-886.
38. Xiao GH, Gallagher R, Shetler J, Skele K, Altomare DA, Pestell RG et al. (2005). Mol Cell Biol 25: 2384-2394.